The case states that this facility admits to pouring cidex opa high level disinfectant into the rapicide pa bottle to be used in their medivators dsd edge automated endoscope reprocessor.Cidex opa and rapicide pa are not interchangable in the dsd edge machine, therefore endoscopes reprocessed were not properly disinfected.There is potential for cross contamination.Two medivators sales representatives visited this facility and confirmed this facility was using cidex opa in their dsd edge machine.The facility made claims to having their own data that showed the opa was acceptable to use in the dsd edge aer.The sales representative reported that the materials manager stated the practicing physicians did their own research.The product specifications of cidex opa in corelation to the dsd edge reprocessing cycle requirements are completely different.The facilities practices do not follow the dfu for the medivators dsd-edge machine, nor does it meet the compliance standards approved by the fda.The continuation of these practices has concern for inadequate disinfection of endoscopes being used on patients and potential for cross contamination.Medivators training, technical service, sales, and regulatory personnel have all contacted this facility to advise on the importance of following proper reprocessing guidelines.To date, there are no confirmed reports of patient injury or illness as a result of this incident.This complaint will continue to be maintained within medivators complaint system.
|